Linda X.H. Yuan - Concepedia

Concepedia

Author

Linda X.H. Yuan

The University of Texas MD Anderson Cancer Center

Also Known As

L.X.H. Yuan, Linda X H Yuan, Linda X Yuan, Linda X. H. Yuan, Linda X.H. Yuan, Linda Yuan, Linna Yuan, Yuan, Linda

13

Publications

1.5K

Citations

11

H-Index

21

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Translational Research in Oncology

LX

About

Linda X.H. Yuan is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, vascular biology, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	50
2	Engineering	1	1	34
3	Cell Biology	1	1	34
4	Immunology	1	1	16
5	Pathology	1	1	16

Linda X.H. Yuan

×

11

Publications

1.5K

Citations

11

H-Index

	Year	Citations
Insulin-like Growth Factor-I Receptor/Human Epidermal Growth Factor Receptor 2 Heterodimerization Contributes to Trastuzumab Resistance of Breast Cancer Cells Rita Nahta, Linda X.H. Yuan, Bing Zhang, Cancer Research	2005	792
Lapatinib induces apoptosis in trastuzumab-resistant breast cancer cells: effects on insulin-like growth factor I signaling Rita Nahta, Linda X.H. Yuan, Yi Du, Molecular Cancer Therapeutics	2007	263
Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells Quanri Jin, Linda X.H. Yuan, Delphine R. Boulbés, Breast Cancer Research	2010	132
Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer. Francisco J. Esteva, Ayşegül A. Şahin, George Z. Rassidakis, PubMed	2003	73
PEA-15 Inhibits Tumorigenesis in an MDA-MB-468 Triple-Negative Breast Cancer Xenograft Model through Increased Cytoplasmic Localization of Activated Extracellular Signal-Regulated Kinase Chandra Bartholomeusz, Ana M. González-Angulo, Anna Kazansky, Clinical Cancer Research	2010	62
Phase I/II Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination with Doxorubicin and Docetaxel in Breast Cancer Stacy L. Moulder, W. Fraser Symmans, Daniel J. Booser, Clinical Cancer Research	2008	58
B cell translocation gene 1 contributes to antisense Bcl-2-mediated apoptosis in breast cancer cells Rita Nahta, Linda X.H. Yuan, Derek J. Fiterman, Molecular Cancer Therapeutics	2006	46
Fluorescent Sensors Based on Cu-Doped Carbon Quantum Dots for the Detection of Rutin Cheng-ya Wang, Shan‐Zhai Shang, Xudong Zheng, Journal of the Brazilian Chemical Society	2018	41
Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancer Fabrice André, Rita Nahta, Rosa Conforti, Annals of Oncology Breast OncologyEngineeringEarly-stage Breast CancerMedicineExpression Patterns	2007	34
Bcl-2 Antisense Oligonucleotide Overcomes Resistance to<i>E1A</i>Gene Therapy in a Low HER2-Expressing Ovarian Cancer Xenograft Model Chandra Bartholomeusz, Hiroaki Itamochi, Linda X.H. Yuan, Cancer Research	2005	24

Page 1